Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/6/2018
SIETES contiene 92380 citas

 
 
 1 a 7 de 7 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Pottegård A, Pedersen SA, Alba S, Schmidt J, Hölmich LR, Friis S, Gaist D. Association of hydrochlorothiazide use and risk of malignant melanoma. JAMA Intern Med 2018:29 de mayo. [Ref.ID 102645]
2. Cita con resumen
Friis S, Riis AH, Erichsen R, Baron JA, Sorensen HT. Low-dose aspirin or nonsteroidal anti-inflammatory drug use and colorectal cancer risk: a population-based, case-control study. Ann Intern Med 2015;163:347-55. [Ref.ID 99513]
3.Enlace a cita original Cita con resumen
Andersen L, Friis S, Hallas J, Ravn P, Kristensen BW, Gaist D. Hormonal contraceptive use and risk of glioma among younger women a nationwide case-control study. Br J Clin Pharmacol 2015;79:677-84. [Ref.ID 98752]
4. Cita con resumen
Pottegard A, Friis S, Andersen M, Hallas J. Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study. Br J Clin Pharmacol 2013;75:1356-64. [Ref.ID 95330]
5. Cita con resumen
Thisted H, Jacobsen J, Munk EM, Norgaard B, Friis S, McLaughlins JK, Sorensen HT, Johnsen SP. Statins and the risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther 2006;23:185-90. [Ref.ID 75842]
6.Tiene citas relacionadas Cita con resumen
Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Norgard B, Friis S, Sorensen HT. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDS. A population-based case-control study. Arch Intern Med 2005;165:978-84. [Ref.ID 73904]
7. Cita con resumen
Olsen JH, Sorensen HT, Friis S, McLaughlin J K, Steffensen FH, Nielsen G L, Andersen M, Fraumeni JF, Olsen J. Cancer risk in users of calcium channel-blockers. Pharmacoepidemiol Drug Saf 1997;6:31. [Ref.ID 34059]
Seleccionar todas
 
 1 a 7 de 7